Auh June-Sun – Chairman, Ahngook Pharm, South Korea
Auh June-Sun, chairman of Ahngook Pharm, describes the company’s increased focus on R&D and doing US FDA clinical trials. Can you describe your background and introduce yourself to our readers?…
The Korea Medical Devices Industry Association (KMDIA) is a trade association committed to improving public health and development of the industry by advocating companies that manufacture, import, export, or sell medical devices since its foundation in 1999.
The Association has around 750 members, bringing these companies together to share information and experience to disseminate the latest technologies and facilitate access to high-quality, affordable medical devices in Korea. The KMDIA is a valuable partner to government authorities such as the Ministry of Health and Welfare and the Ministry of Food and Drug Safety actively presenting policy proposals and regulation ideas, while offering extensive support to Korean medical devices manufacturers compete and grow further in the global market.
The medical devices industry continues rapid growth despite economic slowdown across the world. The factors that drive such growth include: aging society, growing anti-aging industry as a result of higher income, greater interest in health and wellness, government policies that value higher standard of life, emerging latest technologies and biomedical innovation. The Korean government designated the medical devices industry as one of its priority “growth engines” aspiring to lift Korea to global top 5 in the industry by 2018.
The Association also supports foreign and multi-national medical devices companies by providing market intelligence and statistics while assisting them in regulatory and approval procedures. Local and foreign firms are brought together to enter into business discussion and invited to exhibitions hosted by the KMDIA. The MOUs with the counterparts in different regions, such as AdvaMed and EucoMed, are part of the efforts to build networks and promote interactions among member companies, to eventually promote Korea as an attractive market.
The KMDIA is a dedicated partner to all members who seek assistance and partnership.
Contact details:
8~9F, Yeosam Bldg, 123 Teheran-ro, Gangnam-gu, Seoul Korea (135-748)
Tel: +82 2 596 7404
Fax: +82 2 596 7401
kmdia@kmdia.or.kr
www.kmdia.or.kr
Auh June-Sun, chairman of Ahngook Pharm, describes the company’s increased focus on R&D and doing US FDA clinical trials. Can you describe your background and introduce yourself to our readers?…
Lee Kyoung-Ryul has served as Chairman of SCL Healthcare Group since 2007. He discusses the diagnostic service providers’ extensive network in Korea as well as their ambitious plans to export…
On February second, the Korean Ministry of Health and Welfare announced the start of a second round of financing to the biopharmaceutical industry, as part of the Global Pharmaceutical Industry…
With a wealth of experience in different countries around the world, Christophe Piganiol came to Korea as general manager of Zuellig Pharma in 2010. Today he discusses the importance of…
Brian Wang, CEO of Korean super-generics developer GL PharmTech, discusses Korea’s relative strengths in different stages of R&D, and how this motivated the foundation and evolution of GL PharmTech. What…
Liz Chatwin came to Korea as general manager of AstraZeneca in the fall of 2013, following a period working at the company’s Chinese affiliate for several years. She contrasts the…
Lee Han-Koo, president of Daehwa Pharmaceutical, explains his strategy to corner the transdermal drug delivery system (TDDS) market through innovative patch products as well as a special focus on oral…
James Jun, CEO of KT&G Life Sciences, discusses his company’s new entry into the Korean pharma market and the role that the KT&G brand can play in accelerating its drug…
Korean success story Boryung has a goal to become the number one domestic pharmaceutical company in the coming years. The company’s CEO, Choi Tae-Hong, discusses this strategy and the victory…
Bae Byoung-Jun, director general of the Bureau of Health Industry at Korea’s Ministry of Health and Welfare, outlines the history and structure of the Korean healthcare system and highlights the…
LSK Global PS CEO Young-Jack Lee discusses the influence of global CROs on the quality of Korean research, and outlines his own strategy for competing in the marketplace and growth…
Sanofi’s Korean affiliate is the fifth largest recipient of clinical trial investments after the United States, France, Germany and the United Kingdom. Kay Bae, general manager, discusses the benefits of…
See our Cookie Privacy Policy Here
